Clinical Trial Aims to Improve Lung Cancer Detection in Smokers

Edmundo Rubio, MD, is the principal investigator for a clinical trial that may help improve early detection for current and former smokers through blood samples. This study aims to validate blood-based biomarkers for identifying heavy cigarette smokers at the highest risk of having asymptomatic early-stage lung cancer, warranting screening by low-dose CT. Learn more: https://bit.ly/48W2RnW